Alteration in ACE2 expression has been associated with COVID-19 severity; in particular, virus-mediated down-regulation of ACE2 fosters a pro-inflammatory response, which, in the acute phase of the infection, might lead to a more severe illness [47]. The gene discussed is ACE2; the disease is COVID-19.